Rod Rezaee MD
Head & Neck Microvascular Surgery, Head & Neck Oncologic Surgery
Assistant Professor, Otolaryngology and Head & Neck Surgery, Case Western Reserve University School of Medicine
Join to view full profile
11100 Euclid AveCleveland, OH 44106
Phone+1 216-844-6000
Fax+1 216-201-5157
Dr. Rezaee is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Rod Rezaee is an otolaryngologist-head and neck surgeon in Cleveland, OH and is affiliated with multiple hospitals in the area, including University Hospitals Cleveland Medical Center, Seidman Cancer Center, and University Hospitals Ahuja Medical Center. He received his medical degree from The Ohio State University College of Medicine and has been in practice 21 years. He specializes in head & neck surgical oncology, head and neck microvascular reconstructive surgery, thyroid and parathyroid surgery, melanoma, advanced skin cancers, facial trauma and reconstructive surgery.
Education & Training
Ohio State University HospitalResidency, Otolaryngology - Head and Neck Surgery, 1997 - 2001
Mount Carmel Health SystemInternship, Transitional Year, 1996 - 1997- Ohio State University College of MedicineClass of 1996
Certifications & Licensure
OH State Medical License 1997 - 2028
NY State Medical License 2001 - 2003
American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts FollowMyHealth, Allscripts, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR, Allscripts, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2014, 2016-2017
Publications & Presentations
PubMed
- Danvatirsen plus pembrolizumab versus pembrolizumab for recurrent and/or metastatic head and neck squamous cell carcinoma (PEMDA-HN): a randomized, phase 2 trial.Nabil F Saba, Marshall Posner, Kevin Harrington, Prakash Neupane, Rod Rezaee
Clinical Cancer Research. 2026-08-19 - 1 citationsTotal Laryngectomy Length of Stay Association With Diagnosis Related Group Classification.Trisha Shang, Claudia I Cabrera, Rachel A Kominsky, Nicole Fowler, Shawn Li
The Laryngoscope. 2026-04-01 - Long-Term Opioid Use After Treatment of Head and Neck Cancers: A Systematic Review and Meta-analysis.Ross Rosen, John Richter, Claudia I Cabrera, Daniel Karasik, Jayanth Rajan
Otolaryngology--Head and Neck Surgery. 2026-01-01
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: